Bioton SA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bioton SA with three other
pharmaceutical manufacturers in Europe:
sales of 202.76 million Romanian Leu [US$49.33 million]
Summit Therapeutics PLC
of UNITED KINGDOM
(£43.01 million [US$56.52 million]
of which 100%
was Drug Discovery), and
based in ITALY
(48.34 million Euros [US$57.35 million]
During the year ended December of 2019, sales at
Bioton SA were 202.03 million Polish New Zlotys (US$52.45 million).
decrease of 16.2%
versus 2018, when the company's sales were 241.17 million Polish New Zlotys.